2022 American Transplant Congress
Adult-to-Adult Living Donor Liver Transplantation in Acute Liver Failure – Do Outcomes Justify the Risks?
*Purpose: Living-donor Liver Transplantation(LDLT) has emerged as a safe and effective alternative in children and adults with pre-existing liver diseases. Utilization of LDLT for patients…2022 American Transplant Congress
Retransplantation in a High-Volume Institution: Historical, Socioeconomic and Survival Trends
The Mount Sinai Hospital, New York, NY
*Purpose: Retransplantation for liver allograft failure is a challenge within the field. The evolution of organ allocation policy from Child to MELD in 2002 and…2022 American Transplant Congress
Non-HLA Antibodies to G Protein-Coupled Receptors and Allograft Survival in Pediatric Kidney Transplant Recipients: Short- and Long-Term Outcomes
*Purpose: We have recently shown that the non-HLA antibodies to angiotensin II type 1 receptor (AT1R-Ab) and endothelin-1 type A receptor (ETAR-Ab) are prevalent and…2022 American Transplant Congress
Outcomes of Simultaneous Kidney Pancreas Transplantation in Patients with Type-1 and Type-2 Diabetes Mellitus
*Purpose: Advantages for type-2 diabetes mellitus (T2DM) patients receiving simultaneous kidney-pancreas transplantation (SKPT) as compared to kidney transplantation are shorter waiting times and availability of…2022 American Transplant Congress
Effect of Anti Thymocyte Globulin Induction Therapy in Kidney Transplantation Network Meta-Analysis Using Recent Data
Inha University, Incheon, Korea, Republic of
*Purpose: The use of induction immunosuppressant agents in transplantation is important factors in preserving graft kidney function to prevent rejection. However the question of which…2022 American Transplant Congress
Telemedical Surveillance and Optimized Treatment of Blood Pressure in Kidney Transplant Recipients
*Purpose: Patients with chronic kidney disease suffer often from cardiovascular diseases, especially high blood pressure and its complications such as stroke and heart attack. After…2022 American Transplant Congress
Sirolimus Regimens After Kidney Transplantation: Role of Pre-Transplant Risk Factors in Modifying the Risk of Mortality in Adult Recipients
1University of Florida, Gainesville, FL, 2University of Rhode Island, Kinston, RI
*Purpose: We aimed to investigate the role of risk factors in modifying the association of sirolimus with mortality in kidney transplant (KT) recipients (KTRs).*Methods: Using…2022 American Transplant Congress
Liver Transplantation in Patients with Portal Vein Thrombosis: Implications and Outcomes
Liver and Pancreas Transplant Center, UCLA, Los Angeles, CA
*Purpose: Preoperative bland portal vein thrombosis (PVT) is common in Liver transplant (LT) candidates and has been suspected to negatively impact post-LT outcomes, however studies…2022 American Transplant Congress
Four-Year Patient Survival After Simultaneous Pancreas-Kidney Transplantation According to Graft Status Using Kaplan-Meier Survival Method and Competing Risk Model
*Purpose: Aim of this study is to compare the patient survival submitted to SPKT according to the status of graft losses, kidney, pancreas, or both…2022 American Transplant Congress
Clinical Impact of a Modified Lung Allocation Score That Mitigates Selection Bias
*Purpose: The U.S. lung allocation system uses the Lung Allocation Score (LAS) to prioritize lung transplant candidates. Selection bias, induced by dependent censoring of waitlisted…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 66
- Next Page »